Here, we demonstrated that the EP300-ZNF384 fusion protein substantially induces the expression of IL3Rα, which contributes to an acquired growth advantage of B-ALL cells in the presence or absence of IL-3. The gene discussed is IL3RA; the disease is precursor B-cell acute lymphoblastic leukemia.